
CPHI India 2026
11/2026 – 11/2026
A sister concern of MM Pharma, Cu-V-Kar handles finished dosage formulation, contract manufacturing and franchise operations, manufacturing pharmaceutical and nutraceutical products across softgel antibiotic capsules, B-complex capsules, liquid orals, dry syrups, suspensions, antibiotic and general tablets, coated, bilayered, sustained- and extended-release tablets, and ointments, as well as Ayurvedic capsules and syrups using advanced extraction methods. The company operates its own manufacturing units in Dehradun and Chennai, holding WHO-GMP and ISO certifications.

Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen